SELP and Insulin resistance: Despite incubation with the most potent physiological platelet inhibitor, platelets from individuals with insulin resistance continued to express CD62P and activated integrin αIIbβ3, making them primed to participate in platelet–neutrophil and platelet–fibrinogen interactions, respectively.